Biosensorix is a privately held diagnostic company that provides affordable tools enabling fast and accurate life-saving decisions. The company is focused on bringing quantitation to rapid point-of-care testing, allowing earlier and precise treatment that will benefit patients in developing countries and worldwide. The initial technologies target dengue diagnosis and will extend to disease marker detection areas where quantitation is vital and currently unmet.

*Note: If you are a Startup and want to tell your startup story on our Pitchdeck Asia show, Click here - http://www.pitchdeck.asia/pda-soundcloud*